The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 7.50 (1.80%)
Spread: 10.00 (2.381%)
Open: 417.50
High: 425.00
Low: 417.50
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, PDMR Dealings & TVR

23 Dec 2022 08:30

RNS Number : 8915K
Avingtrans PLC
23 December 2022
 

23 December 2022

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Exercise of Options, PDMR Dealings and Total Voting Rights

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces transactions involving its shares by certain PDMRs (including Executive Directors), and other staff members pursuant to the Company's Executive Shared Ownership Plan ("ExSOP") and Company Share Option Plan ("CSOP").

ExSOP

On 21 December 2022, the Company was notified of the exercise of certain option awards over ordinary shares of 5p each in the Company ("Ordinary Shares") in the ExSOP. The option awards were issued to the PDMRs in November 2018 and December 2019. The vesting criteria, being growth in adjusted basic earnings per share equalling the increase in the retail price index over the three year vesting period, has been achieved.

Details of the exercise of options by PDMRs, together with the subsequent beneficial holdings of each individual following the transactions are set out below:

PDMR / Role

ExSOP Plan

ExSOP options exercised

Number of Ordinary Shares which have vested to each Director

Beneficial interest in Ordinary Shares following the transaction1

Percentage of Enlarged Total Voting Rights held following exercise

Austen Adams (MD, Process Solutions & Rotating Equipment)

FY 2019

100,000

33,860

175,607

0.54%

Steven King (CFO)

FY 2018

100,000

45,503

406,938

1.26%

Steve McQuillan (CEO)

FY 2018

115,000

52,328

468,987

1.45%

1Including Persons Closely Associated

The ExSOP options exercised at a price of 440p per option, being the closing mid-market price on 21 December 2022.

The exercise of the awards under the ExSOP have been satisfied by the reallocation of 131,691 existing Ordinary Shares already in the employees' share trust.

CSOP Exercise

In addition to the ExSOP exercise, on 21 December 2022, the Company was notified that certain employees exercised a total of 109,000 options over Ordinary Shares pursuant to the Company's FY 2019 Approved CSOP and FY2019 Unapproved CSOP (together, the "CSOP Options").

Issue of Equity

Exercise of the CSOP Options have been satisfied through the issue of 109,000 new Ordinary Shares.

Application has been made for admission to trading on AIM for the 109,000 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 30 December 2022.

Total Voting Rights

Following the issue of the 109,000 new Ordinary Shares, the Company will have a total of 32,250,445 Ordinary Shares in issue. The Company does not hold any shares in Treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

 

Singer Capital Markets (Nominated Adviser and Broker)

02074 963000

Shaun Dobson / Alex Bond / Oliver Platts (Investment Banking)

 

 

IFC Advisory (Financial PR)

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

 

 

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve McQuillan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ExSOP Option Awards over Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Exercise of Options under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

440p

115,000

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve McQuillan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Award of Ordinary Shares which have vested under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

52,328

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ExSOP Option Awards over Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Exercise of options under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

440p

100,000

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Award of Ordinary Shares which have vested under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

45,503

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ExSOP Option Awards over Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Exercise of options under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

440p

100,000

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

ISIN: GB0009188797

 

b)

 

Nature of the transaction

 

 

Award of Ordinary Shares which have vested under the ExSOP

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

33,860

 

 

 

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

21 December 2022

f)

 

Place of the transaction

 

 

Off market

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTFDLVFIF
Date   Source Headline
29th Jun 20217:00 amRNSMetalcraft training school planning go-ahead
2nd Jun 20217:00 amRNSBooth Industries Reincorporates
1st Jun 20217:00 amRNSMetalcraft secures Phase 2 Sellafield box contract
29th Apr 20214:30 pmRNSDirector Shareholdings, Exercise of Options & TVR
13th Apr 20217:00 amRNSExercise of Options and Total Voting Rights
12th Apr 20211:16 pmRNSHolding(s) in Company
9th Apr 20219:59 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector Shareholdings, Exercise of Options & TVR
12th Mar 20217:00 amRNSDisposal of Peter Brotherhood Limited
10th Feb 20217:00 amRNSInterim Results
29th Jan 20217:00 amRNSCompletion of Acquisition
26th Jan 20212:11 pmRNSHolding(s) in Company
26th Jan 202110:15 amRNSHolding(s) in Company
21st Jan 20217:00 amRNSBooth secures £2.9m contract extension
13th Jan 20217:00 amRNSTrading Update and Notice of Results
6th Jan 20212:40 pmRNSHolding(s) in Company
5th Jan 20217:00 amRNSAcquisition of Majority Stake in new Medtech JV
16th Dec 202011:51 amRNSExercise of Options and Total Voting Rights
14th Dec 20201:16 pmRNSHolding(s) in Company
24th Nov 20202:51 pmRNSEmployee & PDMR Share Incentive Awards
18th Nov 202012:54 pmRNSResult of AGM
4th Nov 20207:00 amRNSExercise of Options, PDMR Dealings and TVR
3rd Nov 202012:06 pmRNSHolding(s) in Company
28th Oct 20204:44 pmRNSHolding(s) in Company
26th Oct 20201:31 pmRNSHolding(s) in Company
23rd Oct 20203:30 pmRNSHolding(s) in Company
23rd Oct 20207:55 amRNSCompletion of Placing in Avingtrans plc
22nd Oct 20206:09 pmRNSClose of Bookbuild
22nd Oct 20204:35 pmRNSProposed Placing in Avingtrans plc
16th Oct 20207:00 amRNSNotice of AGM
7th Oct 20207:00 amRNSExercise of Options & TVR
6th Oct 20209:27 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPreliminary Results for the year ended 31 May 2020
29th Sep 20207:00 amRNSBooth Industries secures £36m HS2 contract
15th Sep 20207:00 amRNSNotice of Results and Q1 Trading Update
1st Sep 20207:00 amRNSPDMR Exercise of Options and Total Voting Rights
7th Jul 20207:00 amRNSTrading Update and Contract Wins
9th Apr 20207:00 amRNSCovid-19 Update
10th Mar 20202:14 pmRNSHolding(s) in Company
26th Feb 20207:00 amRNSInterim Results
23rd Jan 20207:00 amRNSTrading Update and Notice of Results
17th Jan 20208:00 amRNSHolding(s) in Company
13th Jan 20201:37 pmRNSExercise of Options and Total Voting Rights
13th Jan 20207:00 amRNSHayward Tyler Awarded £2m Solar Contract in Dubai
23rd Dec 20191:57 pmRNSHolding(s) in Company
20th Dec 20197:00 amRNSExercise of Options and Total Voting Rights
18th Dec 20197:00 amRNSShare Incentive Awards, Issue of Equity and TVR
14th Nov 201911:15 amRNSResult of AGM and Change of Director
8th Nov 20197:00 amRNSPDMR Shareholding
1st Nov 20193:37 pmRNSDirector Shareholdings, Exercise of Options & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.